Consolidated Statements Of Cash Flow - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities
Net (loss) income	$ (2,559)	$ 1,561
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization, includes $388 amortization of ROU assets (imputed)	1,380	1,692
Goodwill and intangible asset impairment	2,246
Stock compensation expense	527	533
Deferred income taxes	(362)	186
Loss on disposal of assets	289	15
Allowance for doubtful accounts	9	124
Changes in assets and liabilities:
Receivables	3,133	1,216
Inventories	498	339
Accounts payable	(1,252)	(783)
Accrued liabilities and expenses	324	(1,593)
Deferred revenue	(626)	(462)
Other assets and liabilities	(415)	(2,200)
Net cash provided by operating activities	3,192	628
Cash Flows from Investing Activities
Purchases of short-term investments	(1,486)	(2,199)
Sales of short-term investments	2,624	2,431
Capital expenditures	(440)	(809)
Capital expenditures - intangibles	(202)	(311)
Net cash provided by (used for) investing activities	496	(888)
Cash Flows from Financing Activities
Proceeds from lines of credit	2,500
Payments on short-term borrowings		(155)
Proceeds from stock plans	15	329
Cash payment for shares surrendered upon vesting of RSU's to cover taxes	(28)	(55)
Net cash provided by financing activities	2,487	119
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(131)	(150)
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	6,044	(291)
Cash, Cash Equivalents and Restricted Cash, July 1	4,843	5,996
Cash, Cash Equivalents and Restricted Cash, March 31	10,887	5,705
Supplemental Disclosure of Cash Flow Information
Cash paid during the period for interest	44	73
Cash paid during the period for income taxes	247	553
Cash and cash equivalents	10,564	5,429
Restricted Cash included in Short-term Investments	323	276
Cash, Cash Equivalents and Restricted Cash, March 31	$ 10,887	$ 5,705